| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |